Showing 1801-1810 of 7865 results for "".
Journal Scan of Three Trials for an Rx Option
https://practicaldermatology.com/topics/psoriasis/deucravacitinib-journal-scan/29155/A review of three clinical trials, with introduction and commentary by Linda Stein Gold, MD. Click the image to download the full supplement.Advantages of More Topical Gel
https://practicaldermatology.com/series/pdt-in-practice/advantages-of-more-topical-gel/29176/Dr. Ashish Bhatia discusses increased dosing of a PDT photosensitizer for both lesion-directed and field-directed treatment of actinic keratosis.Bring Pediatric Pearls Into Practice
https://practicaldermatology.com/conferences/maui-derm-2024/bring-pediatric-pearls-into-practice/20265/Resident Of Distinction Award-winner Maria Buethe, MD, PhD, a pediatric dermatology fellow at Rady Children’s Hospital in San Diego, talks about her favorite session at Maui Derm 2024 sharing technical and practice pearls for the treatment of dermatological conditions in children, including an interWhat Could Go Wrong with Fillers?
https://practicaldermatology.com/conferences/maui-derm-2024/what-could-go-wrong-with-fillers/20253/Joel L. Cohen, MD, explains the importance of understanding “what lies beneath” in order to more accurately evaluate post-procedure reactions and know how and when to intervene.What’s New With Neuromodulators?
https://practicaldermatology.com/conferences/maui-derm-2024/whats-new-with-neuromodulators/20252/Joel L. Cohen, MD, discusses the currently available neuromodulators as well as what’s on the radar, including ready-to-use liquid toxins and more.The Secret Sauce for Managing AD
https://practicaldermatology.com/conferences/scale-2023/the-secret-sauce-for-managing-ad/20190/James Del Rosso, DO, discusses new and upcoming therapies for atopic dermatitis including monoclonal antibodies and JAK inhibitors.Why is CSF Different?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/why-is-csf-different/20124/Discover why CSF is different from other meetings. Attendees and faculty share their CSF experience and describe why they think the meeting and its new Nashville home make for “a great program.”What Dermatologists Ought to Know About Cyspera®
https://practicaldermatology.com/topics/general-topics/what-dermatologists-ought-to-know-about-cyspera/20103/Cyspera has become a "go-to topical product for pigment," says Michael H. Gold, MD. He describes the Cyspera Intensive System and its benefits for the management of hyperpigmentation. He discusses advancements in the Cyspera formulation that enhance outcomes.DermWireTV: PCA to Space Station; ASDS Pandemic Data; LaRoche-Posay, GW Partnership
https://practicaldermatology.com/topics/practice-management/dermwiretv-pca-to-space-station-asds-pandemic-data-laroche-posay-gw-partnership/20059/The "Great Resignation" forcing some dermatology practices to operate with reduced staffing is just one of the lingering impacts of the COVID-19 pandemic on practices, according to results of a survey by the American Society for Dermatologic Surgery. PCA skin is sending the first-ever private sectorA Promising Pipeline
https://practicaldermatology.com/conferences/maui-derm-2022/a-promising-pipeline/20051/Joel L. Cohen, MD says he's excited about a number of devices he's currently investigating for a wide-variety of medical and aesthetic dermatologic treatments. From body contouring to acne to hair removal, Dr. Cohen shares insights on advancing technologies for several indications.